March 20th, 2018
Harvard bioengineers’ biomaterial-based cancer immunotherapies to be developed by Novartis
Licensing and collaboration agreement aims to bring biomaterial-based cancer immunotherapies into clinical development
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
Tag: David Mooney
July 27th, 2017
Sticky when wet: A strong adhesive for wound healing
Medical-grade bio-glue inspired by slugs sticks to biological surfaces without toxicity
November 30th, 2015
A better way to change the fate of stem cells
Harvard researchers have developed a new, more precise way to control the differentiation of stem cells into bone cells.
